+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nefazodone"

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Nefazodone is an antidepressant medication used to treat mental disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD). It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of serotonin and norepinephrine in the brain. Nefazodone is generally well-tolerated and has fewer side effects than other antidepressants. It is available in both immediate-release and extended-release formulations. Nefazodone is used in combination with other medications to treat major depressive disorder, generalized anxiety disorder, and panic disorder. It is also used to treat bipolar disorder, obsessive-compulsive disorder, and premenstrual dysphoric disorder. Nefazodone is not recommended for use in children or adolescents. The Nefazodone market is a small but growing segment of the mental disorders drugs market. It is used to treat a variety of mental health conditions, and its efficacy and safety profile make it an attractive option for many patients. Some companies in the Nefazodone market include Pfizer, Mylan, and Teva Pharmaceuticals. Show Less Read more